Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 10/20 | 0.71 |
| ▸ | GRIN3B | O60391 | 10/20 | 0.71 |
| ▸ | GRIN1 | Q05586 | 10/20 | 0.71 |
| ▸ | GRIN2A | Q12879 | 10/20 | 0.71 |
| ▸ | GRIN2B | Q13224 | 10/20 | 0.71 |
| ▸ | GRIN2C | Q14957 | 10/20 | 0.71 |
| ▸ | GRIN3A | Q8TCU5 | 10/20 | 0.71 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.41 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657942 | 0.89 | GRIN2D (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL658278 | 0.87 | GRIN2D (0.65) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL657934 | 0.85 | GRIN2D (0.62) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL21002581 | 0.85 | GRIN2D (0.48) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL292537 | 0.83 | GRIN2D (1.00) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL31431345 | 0.82 | GRIN1 (0.96) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL25799584 | 0.82 | GRIN1 (0.70) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL541940 | 0.82 | GRIN1 (0.96) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL16269329 | 0.80 | GRIN2D (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL16274382 | 0.80 | GRIN2D (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116262698-B | Novel 2- (1-hydroxypentyl) benzoic acid naphthenamine salt | CHENGDU SHIBEIKANG BIOLOGICAL MEDICINE TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4685128-A1 | NOVEL 2-(1-HYDROXYPENTYL) BENZOIC ACID CYCLOALKYL AMINE SALT | Chengdu Shibeikang Biomedical Technology Co., Ltd. (CN) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024193721-A1 | NOVEL 2-(1-HYDROXYPENTYL) BENZOIC ACID CYCLOALKYL AMINE SALT | 成都施贝康生物医药科技有限公司 | 2024-09-26 | — | — | WO | disclosed |
| CN-116262698-A | Novel 2- (1-hydroxypentyl) benzoic acid naphthenamine salt | 成都施贝康生物医药科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| WO-2020232246-A1 | COMPOSITIONS AND METHODS AGAINST STRESS-INDUCED AFFECTIVE DISORDERS AND THEIR ASSOCIATED SYMPTOMS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-11-19 | — | — | WO | disclosed |
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | disclosed |
| US-20060199816-A1 | Aryl sulfonyl piperidines | GILLESPIE PAUL | 2006-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | GRIN2D 399/4885GRIN3B 217/4885GRIN1 215/4885 |
| US-20060199816-A1 | Aryl sulfonyl piperidines | GPR119, SLC5A2, GLS2 | GRIN2D 2918/4885GRIN3B 4009/4885GRIN1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.